PHT Corporation Records Outstanding Q2 with 53% Increase in Bookings and Groundbreaking ePRO Data Collection and Reporting

Global electronic patient reported outcome (ePRO) market and technology leader sees strongest Q2 bookings in history; publishes industry’s first free ePRO modality decision tool, and Smartphone app for clinical trial reporting

BOSTON & GENEVA--(BUSINESS WIRE)-- PHT Corporation completed its most successful Q2 in company history on June 30, 2011. The strong, outstanding results reflect the growing worldwide adoption of its market-leading ePRO Systems. PHT is the global innovator in ePRO solutions that maximize the collection of high quality data from clinical trial patients. Total bookings were up 53% in the second quarter of 2011 vs. the same period in the previous year. Total revenues through the first half of the year rose 10% and net income increased by 9% over the same period in 2010. The number of trials deployed increased 38% for the first half of the year vs. the same period in 2010. PHT’s strong financial performance demonstrates the increased demand in the clinical research market for collecting high quality patient reported outcome data.

PHT’s LogPad®, SitePad®, eSense® and NetPRO™ Systems all were in strong demand during the second quarter as trial sponsors consistently turned to PHT for the industry’s most innovative, reliable and easy to use ePRO offerings. There was significant growth for PHT’s ePRO solutions across the industry and in key target therapeutic areas including oncology, diabetes, gastrointestinal, and respiratory.

PHT President and CEO Phil Lee said, “Pharmaceutical companies and CROs come to PHT for world-class science, products, support, and cost-efficiency. Sponsors benefit from our in-depth experience, knowledge and best practices culled from hundreds of ePRO trial implementations with patients, sites and trial designs similar to theirs. PHT makes ePRO easy for sponsors, sites and patients.”

During Q2 PHT unveiled three major new ePRO and PRO products and capabilities: the ePRO Modality Tool, SmartReports™ and SmartReports Mobile.

About PHT Corporation

PHT Corporation is the industry's only dedicated full-service ePRO provider. PHT offers clients a comprehensive solution for acquiring, managing and analyzing data collected directly from patients through all phases of clinical development. More than 115 biopharmaceutical companies use PHT's ePRO System to easily collect high quality, regulatory compliant clinical trial data. PHT's proven LogPad®, NetPRO™ and versatile SitePad® Systems deliver the voice of the patient, in 88 languages, from homes and sites in 67 countries around the world. Patient experiences captured firsthand by PHT's ePRO System have been used successfully in at least 20 regulatory submissions and 17 approvals to date resulting in 15 PRO-based label claims for sponsors. For more information on PRO and ePRO innovations, review the interactive content and demonstrations at the award-winning www.phtcorp.com.

PHT, LogPad, NetPRO, SitePad, and SmartReports are registered trademarks and/or trademarks of PHT Corporation.



CONTACT:

For PHT Corporation
Brenda Nashawaty, 617-688-3253
[email protected]

KEYWORDS:   United States  Europe  North America  Massachusetts  Switzerland

INDUSTRY KEYWORDS:   Technology  Data Management  Software  Health  Clinical Trials  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.